Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894978880> ?p ?o ?g. }
- W2894978880 endingPage "91" @default.
- W2894978880 startingPage "91" @default.
- W2894978880 abstract "Nonalcoholic fatty liver disease (NAFLD) is characterized by histological evidence of hepatic steatosis, lobular inflammation, ballooning degeneration and hepatic fibrosis in the absence of significant alcohol use and other known causes of chronic liver diseases. NAFLD is subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). NAFL is generally benign but can progress to NASH, which carries a higher risk of adverse outcomes including cirrhosis, end-stage liver disease, hepatocellular carcinoma and death if liver transplantation is not pursued in a timely fashion. Currently, lifestyle modifications including healthy diet and increased physical activity/exercise culminating in weight loss of 5% to >10% is the cornerstone of treatment intervention for patients with NAFLD. Patients with NAFLD who fail to obtain this goal despite the help of dietitians and regimented exercise programs are left in a purgatory state and remain at risk of developing NASH-related advance fibrosis. For such patients with NAFLD who are overweight and obese, healthcare providers should consider a trial of FDA-approved anti-obesity medications as adjunct therapy to provide further preventative and therapeutic options as an effort to reduce the risk of NAFLD-related disease progression." @default.
- W2894978880 created "2018-10-12" @default.
- W2894978880 creator A5025170630 @default.
- W2894978880 creator A5031150697 @default.
- W2894978880 creator A5037028768 @default.
- W2894978880 creator A5038808879 @default.
- W2894978880 creator A5046756282 @default.
- W2894978880 creator A5060181991 @default.
- W2894978880 creator A5064334136 @default.
- W2894978880 creator A5068997870 @default.
- W2894978880 creator A5079801760 @default.
- W2894978880 date "2018-09-30" @default.
- W2894978880 modified "2023-09-27" @default.
- W2894978880 title "When to Initiate Weight Loss Medications in the NAFLD Population" @default.
- W2894978880 cites W1537391465 @default.
- W2894978880 cites W1901225590 @default.
- W2894978880 cites W1908780918 @default.
- W2894978880 cites W1969939097 @default.
- W2894978880 cites W1984091723 @default.
- W2894978880 cites W1984603193 @default.
- W2894978880 cites W1989320796 @default.
- W2894978880 cites W1992019017 @default.
- W2894978880 cites W1994320162 @default.
- W2894978880 cites W1997671539 @default.
- W2894978880 cites W1999836143 @default.
- W2894978880 cites W2001837599 @default.
- W2894978880 cites W2016253107 @default.
- W2894978880 cites W2021000378 @default.
- W2894978880 cites W2048613643 @default.
- W2894978880 cites W2054192772 @default.
- W2894978880 cites W2069103752 @default.
- W2894978880 cites W2086719465 @default.
- W2894978880 cites W2091106363 @default.
- W2894978880 cites W2110438413 @default.
- W2894978880 cites W2118144789 @default.
- W2894978880 cites W2123931921 @default.
- W2894978880 cites W2124477479 @default.
- W2894978880 cites W2134860420 @default.
- W2894978880 cites W2148449799 @default.
- W2894978880 cites W2154075360 @default.
- W2894978880 cites W2156201970 @default.
- W2894978880 cites W2157338541 @default.
- W2894978880 cites W2164252555 @default.
- W2894978880 cites W2175436961 @default.
- W2894978880 cites W2192722195 @default.
- W2894978880 cites W2204688218 @default.
- W2894978880 cites W2204801845 @default.
- W2894978880 cites W2210843203 @default.
- W2894978880 cites W2215535790 @default.
- W2894978880 cites W2433376106 @default.
- W2894978880 cites W2471504731 @default.
- W2894978880 cites W2550679725 @default.
- W2894978880 cites W2565036592 @default.
- W2894978880 cites W2734724639 @default.
- W2894978880 cites W2738659466 @default.
- W2894978880 cites W2744552086 @default.
- W2894978880 cites W2746751342 @default.
- W2894978880 cites W2750846342 @default.
- W2894978880 cites W2759997926 @default.
- W2894978880 cites W2767704057 @default.
- W2894978880 cites W2890663139 @default.
- W2894978880 cites W4253617746 @default.
- W2894978880 doi "https://doi.org/10.3390/diseases6040091" @default.
- W2894978880 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6313489" @default.
- W2894978880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30274326" @default.
- W2894978880 hasPublicationYear "2018" @default.
- W2894978880 type Work @default.
- W2894978880 sameAs 2894978880 @default.
- W2894978880 citedByCount "11" @default.
- W2894978880 countsByYear W28949788802020 @default.
- W2894978880 countsByYear W28949788802021 @default.
- W2894978880 countsByYear W28949788802022 @default.
- W2894978880 countsByYear W28949788802023 @default.
- W2894978880 crossrefType "journal-article" @default.
- W2894978880 hasAuthorship W2894978880A5025170630 @default.
- W2894978880 hasAuthorship W2894978880A5031150697 @default.
- W2894978880 hasAuthorship W2894978880A5037028768 @default.
- W2894978880 hasAuthorship W2894978880A5038808879 @default.
- W2894978880 hasAuthorship W2894978880A5046756282 @default.
- W2894978880 hasAuthorship W2894978880A5060181991 @default.
- W2894978880 hasAuthorship W2894978880A5064334136 @default.
- W2894978880 hasAuthorship W2894978880A5068997870 @default.
- W2894978880 hasAuthorship W2894978880A5079801760 @default.
- W2894978880 hasBestOaLocation W28949788801 @default.
- W2894978880 hasConcept C126322002 @default.
- W2894978880 hasConcept C2776175330 @default.
- W2894978880 hasConcept C2776954865 @default.
- W2894978880 hasConcept C2777214474 @default.
- W2894978880 hasConcept C2778772119 @default.
- W2894978880 hasConcept C2779102576 @default.
- W2894978880 hasConcept C2779134260 @default.
- W2894978880 hasConcept C2779478299 @default.
- W2894978880 hasConcept C2779609443 @default.
- W2894978880 hasConcept C2780559512 @default.
- W2894978880 hasConcept C2780586474 @default.
- W2894978880 hasConcept C2908647359 @default.
- W2894978880 hasConcept C2911091166 @default.
- W2894978880 hasConcept C511355011 @default.